These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6277822)

  • 1. Cell surface glycoprotein patterns of two EBV-negative lines and their EBV converted sublines.
    Koide N; Wells A; Klein G; Ernberg I
    Intervirology; 1981; 16(3):142-8. PubMed ID: 6277822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the protein composition of Epstein-Barr Virus-negative lymphoma cells after EBV-conversion.
    Siegert W; Mönch T
    Anticancer Res; 1983; 3(1):11-6. PubMed ID: 6299173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus type 1 infection of isogenic Epstein-Barr virus genome-negative and -positive Burkitt's lymphoma-derived cell lines.
    Leinbach SS; Summers WC
    J Virol; 1979 Apr; 30(1):248-54. PubMed ID: 225521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible DNA-RNA tumor virus interaction in human lymphomas: expression of retroviral proteins in Ramos lymphoma lines is enhanced after conversion with Epstein-Barr virus.
    Lasky RD; Troy FA
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):33-7. PubMed ID: 6320170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-density-dependence for growth in agarose of two human lymphoma lines and its decrease after Epstein-Barr virus conversion.
    Montagnier L; Gruest J
    Int J Cancer; 1979 Jan; 23(1):71-5. PubMed ID: 215564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-induced increase in the concanavalin-A receptor density of established EBV-negative lymphoma lines in vitro.
    Siegert W; Mönch T; Valet G
    Exp Hematol; 1980 Nov; 8(10):1173-82. PubMed ID: 6262102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cytotoxicity of tumour promoter TPA for EBV-negative human lymphoma cell lines and their EBV-converted sublines.
    Béchet JM; Guétard D
    Int J Cancer; 1983 Jul; 32(1):61-5. PubMed ID: 6305854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of the lymphoma line "BJAB" by Epstein-Barr virus into phenotypically altered sublines is accompanied by increased c-myc mRNA levels.
    Wennborg A; Aman P; Saranath D; Pear W; Sümegi J; Klein G
    Int J Cancer; 1987 Aug; 40(2):202-6. PubMed ID: 3038758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular size variation of EBNA is determined by the EB viral genome.
    Gergely L; Sternås L; Dillner J; Klein G
    Intervirology; 1984; 22(2):85-96. PubMed ID: 6090339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexose transport in Epstein-Barr virus (EBV) negative lymphoma lines and their EBV converted, virus genome carrying sublines.
    Siegert W; Mönch T
    Blut; 1981 Nov; 43(5):297-305. PubMed ID: 6275931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the amounts of EBV-DNA and EBNA per cell, clonability and tumorigenicity in two ebv-negative lymphoma lines and their EBV-converted sublines.
    Ernberg I; Klein G; Giovanella BC; Stehlin J; McCormick KJ; Andersson-Anvret M; Aman P; Killander D
    Int J Cancer; 1983 Feb; 31(2):163-9. PubMed ID: 6298125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface glycoprotein changes in Epstein-Barr virus-positive and -negative human hematopoietic cell lines.
    van Beek WP; Nilsson K; Klein G; Emmelot P
    Int J Cancer; 1979 Apr; 23(4):464-73. PubMed ID: 220199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between Epstein-Barr virus (EBV) and human cell lines: growth and EBV induction.
    Takimoto T; Iwawaki J; Tanaka S; Umeda R
    ORL J Otorhinolaryngol Relat Spec; 1990; 52(1):40-6. PubMed ID: 2154734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines.
    Klein G; Zeuthen J; Terasaki P; Billing R; Honig R; Jondal M; Westman A; Clements G
    Int J Cancer; 1976 Nov; 18(5):639-52. PubMed ID: 62724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell sensitivity of human lymphoid lines of B-cell origin does not correlate with tumorigenicity or with the expression of certain differentiation markers.
    Torsteinsdottir S; Masucci MG; Lenoir G; Klein G; Klein E
    Cell Immunol; 1984 Jul; 86(2):278-86. PubMed ID: 6329520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
    Klein G; Ehlin-Henriksson B; Schlossman SF
    J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogene expression in isogenic, EBV-positive and -negative Burkitt lymphoma cell lines.
    Glazer PM; Summers WC
    Intervirology; 1985; 23(2):82-9. PubMed ID: 2984143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface glycoprotein patterns of human haematopoietic cell lines.
    Gahmberg CG; Andersson LC; Nilsson K
    IARC Sci Publ (1971); 1978; (24 Pt 2):649-53. PubMed ID: 221389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated viral DNA sequences in Epstein-Barr virus-converted human lymphoma lines.
    Andersson-Anvret M; Lindahl T
    J Virol; 1978 Mar; 25(3):710-8. PubMed ID: 205668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
    Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
    Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.